POET Technologies Reports Second Quarter 2026 Results: Revenue Up 112% Year-Over-Year in Sixth Consecutive Quarter of Sequential Growth

Net loss narrows to ($0.07) per share; quarter-end cash and short-term investments of $796.3 million

TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today reported its unaudited condensed consolidated financial results for the second quarter ended June 30, 2026. Revenue was $569,925, up 13% from the first quarter and 112% from the second quarter of 2025 — the Company’s sixth consecutive quarter of sequential revenue growth. Net loss narrowed to $11.3 million, or ($0.07) per share, from $12.3 million in the first quarter. The Company ended the quarter with $796.3 million in cash and short-term investments following completion of its $400 million financing in May. The Company’s financial results as well as the Management Discussion and Analysis have been filed on SEDAR+. All financial figures are in United States dollars (“USD”) unless otherwise indicated.

A welcome email is on its way. If you don't see it, please check your junk folder.

“The second quarter showed POET’s transition from development to revenue taking hold: our sixth consecutive quarter of sequential revenue growth, a narrowing net loss, and our optical engine production ramp remaining on schedule for the second half of 2026,” said Dr. Suresh Venkatesan, Chairman & CEO of POET Technologies.

“The $400 million strategic investment we completed in the quarter — priced at a premium to market — fundamentally strengthens POET’s financial position, removes the uncertainty associated with our staying power and enables management to focus entirely on executing our commercial and operational objectives,” continued Dr. Venkatesan. “This amount of capital positions POET to accelerate the expansion of our manufacturing capacity in support of anticipated customer demand, including the commercialization and production ramp associated with our collaboration with Lumilens.”

“The appointment of Dr. Sandeep Kumar as Chief Operating Officer adds the operational and manufacturing leadership required as we scale our global operations,” added Dr. Venkatesan. “Together, our strengthened leadership team, significantly enhanced capital resources and expanding commercial opportunities establish the foundation for the next phase of POET’s growth and positions the Company to deliver long-term value for customers and shareholders.”